Discovering

A disciplined, highly targeted approach to discovering new cancer medicines

Go

Developing

Rigorous, definitive clinical trials based on deep biology and chemistry expertise

Go

Delivering

Committed to bringing differentiated new cancer medicines to patients

Go

Iclusig®(ponatinib)

ARIAD's first internally discovered and developed medicine

Go
       

News & Features

Latest News

10/15/14

ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results

Read More

10/10/14

ARIAD Announces Recommendation for Iclusig by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency

Read More

Our Corporate Brochure

A shared commitment to patients and each other. This is ARIAD.

click here for PDF

Print page Share page
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue